191 related articles for article (PubMed ID: 35174786)
21. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
[TBL] [Abstract][Full Text] [Related]
22. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
23. Four patients with cutaneous metastases from medullary thyroid cancer.
Santarpia L; El-Naggar AK; Sherman SI; Hymes SR; Gagel RF; Shaw S; Sarlis NJ
Thyroid; 2008 Aug; 18(8):901-5. PubMed ID: 18651821
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and genetic profile of patients with medullary thyroid cancer treated in the Cancer Centre--Institute of Oncology in Warsaw].
Czetwertyńska M; Kozłowicz-Gudzińska I; Stachlewska-Nasfeter E; Sromek M; Skasko E; Paszko Z
Endokrynol Pol; 2006; 57(4):415-9. PubMed ID: 17006846
[TBL] [Abstract][Full Text] [Related]
25. Multiple endocrine neoplasia type 2.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Tognarini I; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Nov; 1():45. PubMed ID: 17105651
[TBL] [Abstract][Full Text] [Related]
26. Medullary thyroid carcinoma in children.
Viola D; Romei C; Elisei R
Endocr Dev; 2014; 26():202-13. PubMed ID: 25231454
[TBL] [Abstract][Full Text] [Related]
27. Multiple endocrine neoplasia type 2B: more than an endocrine disorder.
O'Riordain DS; O'Brien T; Crotty TB; Gharib H; Grant CS; van Heerden JA
Surgery; 1995 Dec; 118(6):936-42. PubMed ID: 7491537
[TBL] [Abstract][Full Text] [Related]
28. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Ponder MA; Ponder BA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):123-7. PubMed ID: 7641404
[TBL] [Abstract][Full Text] [Related]
29. Medullary Thyroid Carcinoma in a Patient with MEN 1 Syndrome. Case Report and Literature Review.
Friziero A; Da Dalt G; Piotto A; Serafini S; Grego A; Galuppini F; Pennelli G; Sperti C
Onco Targets Ther; 2020; 13():7599-7603. PubMed ID: 32801775
[TBL] [Abstract][Full Text] [Related]
30. Late-Onset Medullary Thyroid Cancer in a Patient with a Germline
Walczyk A; Zgubieński K; Chmielewski G; Hińcza-Nowak K; Kowalik A; Jaskulski J; Kowalska A
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441382
[No Abstract] [Full Text] [Related]
31. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
[TBL] [Abstract][Full Text] [Related]
32. Management of hereditary medullary thyroid carcinoma.
Pappa T; Alevizaki M
Endocrine; 2016 Jul; 53(1):7-17. PubMed ID: 26839093
[TBL] [Abstract][Full Text] [Related]
33. Medullary thyroid carcinoma (MTC): unusual metastatic sites.
Kazakou P; Simeakis G; Alevizaki M; Saltiki K
Endocrinol Diabetes Metab Case Rep; 2021 Sep; 2021():. PubMed ID: 34551391
[TBL] [Abstract][Full Text] [Related]
34. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
35. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
36. RET oncogene mutations in medullary thyroid carcinoma in Mexican families.
González B; Salcedo M; Medrano ME; Mantilla A; Quiñónez G; Benítez-Bribiesca L; Rodríguez-Cuevas S; Cabrera L; de León B; Altamirano N; Tapia J; Dawson B
Arch Med Res; 2003; 34(1):41-9. PubMed ID: 12604374
[TBL] [Abstract][Full Text] [Related]
37. Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines.
Dyhdalo KS; Chute DJ
Cancer Cytopathol; 2018 Jun; 126(6):397-405. PubMed ID: 29579362
[TBL] [Abstract][Full Text] [Related]
38. Sporadic medullary thyroid carcinoma with a pedunculated intraluminal internal jugular vein recurrence: A case report and literature review.
Patten DK; Flora R; Tolley N; Palazzo F
Int J Surg Case Rep; 2012; 3(2):92-6. PubMed ID: 22288056
[TBL] [Abstract][Full Text] [Related]
39. Breast Metastasis from Medullary Thyroid Carcinoma in a Male Patient: Case Report and Review of the Literature.
Mandanas S; Margaritidou E; Christoforidou V; Karoglou E; Geranou C; Chrisoulidou A; Boudina M; Georgopoulos K; Pazaitou-Panayiotou K
Rare Tumors; 2015 May; 7(2):5765. PubMed ID: 26266011
[TBL] [Abstract][Full Text] [Related]
40. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
